The effect of Helicobacter pylori eradication on recovery of platelet level in Idiopathic Trombocytopenic purpura patients
Phase 2
- Conditions
- thrombocytopeny.Idiopathic thrombocytopenic purpura
- Registration Number
- IRCT201202098968N1
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusive Criteria:
Adult with diagnosis of idiopathic thrombocytopenic purpura; H. pylori stool antigen test Positive or positive urease breath test
Exclusive Criteria:
Family history of gastric cancer;History of treatment of H.Pylori infection; History of ulcer or inflammation in stomach or Duodenum.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet count over than 100000. Timepoint: day 0,10,30,60,90,120,150,180 after drug. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method Efficacy of treatment in eradication of H-Pylori. Timepoint: during 6 months(in days 0,10,30,60,90,120) after drug. Method of measurement: Laboratory.